TP53 MUTATIONS AND DEL17P13 PREDICT SIMILAR OUTCOME AND CHEMOREFRACTORINESS IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Cerri, M. [1 ]
Deambrogi, C. [1 ]
Capello, D. [1 ]
Cresta, S. [1 ]
Rasi, S. [1 ]
Sozzi, E. [2 ]
De Paoli, L. [1 ]
Gattei, V. [3 ]
Forconi, F. [2 ]
Gaidano, G. [1 ]
Rossi, D. [1 ]
机构：
[1] Amedeo Avogadro Univ, Div Hematol, Novara, Italy
[2] Univ Siena, Div Hematol & Bone Marrow Transplantat, I-53100 Siena, Italy
[3] CRO, Clin & Expt Oncohematol Unit, Aviano, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0410
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [11] TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Francesca Maria
    Vit, Filippo
    Bittolo, Tamara
    D'Agaro, Tiziana
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vendramini, Elena
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Varaschin, Paola
    Nanni, Paola
    Berton, Michele
    Braida, Alessandra
    Polesel, Jerry
    Cohen, Jared A.
    Santinelli, Enrico
    Biagi, Annalisa
    Gentile, Massimo
    Morabito, Fortunato
    Fronza, Gilberto
    Pozzato, Gabriele
    D'Arena, Giovanni
    Olivieri, Jacopo
    Bulian, Pietro
    Pepper, Chris
    Hockaday, Anna
    Schuh, Anna
    Hillmen, Peter
    Rossi, Davide
    Chiarenza, Annalisa
    Zaja, Francesco
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5566 - 5575
  • [12] Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia
    Fangazio, Marco
    Rasi, Silvia
    Vaisitti, Tiziana
    Monti, Sara
    Cresta, Stefania
    Bruscaggin, Alessio
    Spina, Valeria
    Forconi, Francesco
    Chiaretti, Sabina
    Guarini, Anna
    Deaglio, Silvia
    Foa, Robin
    Gaidano, Gianluca
    Rossi, Davide
    BLOOD, 2011, 118 (21) : 216 - 216
  • [13] Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia
    Bomben, Riccardo
    Rossi, Maria Francesca
    D'Agaro, Tiziana
    Bittolo, Tamara
    Zucchetto, Antonella
    Tissino, Erika
    Pozzo, Federico
    Vit, Filippo
    Bulian, Pietro
    Degan, Massimo
    Zaina, Eva
    Cattarossi, Ilaria
    Nanni, Paola
    Chivilo, Hillarj
    D'Arena, Giovanni Francesco
    Chiarenza, Annalisa
    Santinelli, Enrico
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Del Poeta, Giovanni
    Gattei, Valter
    BLOOD, 2018, 132
  • [14] Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
    Hwang, Steven R.
    Wang, Yucai
    Rabe, Kari G.
    He, Rong
    Kenderian, Saad S.
    Muchtar, Eli
    Hampel, Paul J.
    Kay, Neil E.
    Call, Timothy G.
    Koehler, Amber
    Behnken, Amy L.
    Leis, Jose F.
    Braggio, Esteban
    Shi, Min
    Viswanatha, David S.
    Van Dyke, Daniel L.
    Slager, Susan L.
    Parikh, Sameer A.
    Ding, Wei
    BLOOD, 2022, 140 : 12390 - 12392
  • [15] TP53 MUTATIONS ARE INFREQUENT IN NEWLY-DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA
    Murray, F.
    Zainuddin, N.
    Kanduri, M.
    Gunnarsson, R.
    Smedby, K. Ekstrom
    Enblad, G.
    Jurlander, I.
    Juliusson, G.
    Rosenquist, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 39 - 39
  • [16] Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
    Chauffaille, Maria de Lourdes L. F.
    Zalcberg, Ilana
    Barrero, Wolney Gois
    Bendit, Israel
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (03) : 261 - 268
  • [17] EVALUATION OF TP53 MUTATIONS WITH THE AMPLICHIP P53 ARRAY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): HIGHER SENSITIVITY AND CORRELATION WITH CLINICAL OUTCOME
    Chiaretti, S.
    Tavolaro, S.
    Marinelli, M.
    Messina, M.
    Del Giudice, I.
    Mauro, F.
    Santangelo, S.
    Di Maio, V.
    Piciocchi, A.
    Magliozzi, M.
    Peragine, N.
    Truong, S.
    Patten, N.
    Lawrence, J.
    Ghia, E. M.
    Nanni, M.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 39 - 40
  • [18] Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
    Ahn, Inhye E.
    Tian, Xin
    Wiestner, Adrian
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 498 - 500
  • [19] TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
    Zenz, Thorsten
    Eichhorst, Barbara
    Busch, Raymonde
    Denzel, Tina
    Haebe, Sonja
    Winkler, Dirk
    Buehler, Andreas
    Edelmann, Jennifer
    Bergmann, Manuela
    Hopfinger, Georg
    Hensel, Manfred
    Hallek, Michael
    Doehner, Hartmut
    Stilgenbauer, Stephan
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4473 - 4479
  • [20] Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
    Rossi, Davide
    Fangazio, Marco
    Rasi, Silvia
    Vaisitti, Tiziana
    Monti, Sara
    Cresta, Stefania
    Chiaretti, Sabina
    Del Giudice, Ilaria
    Fabbri, Giulia
    Bruscaggin, Alessio
    Spina, Valeria
    Deambrogi, Clara
    Marinelli, Marilisa
    Fama, Rosella
    Greco, Mariangela
    Daniele, Giulia
    Forconi, Francesco
    Gattei, Valter
    Bertoni, Francesco
    Deaglio, Silvia
    Pasqualucci, Laura
    Guarini, Anna
    Dalla-Favera, Riccardo
    Foa, Robin
    Gaidano, Gianluca
    BLOOD, 2012, 119 (12) : 2854 - 2862
12345